Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis
- PMID: 20628028
- PMCID: PMC2906703
- DOI: 10.1158/1078-0432.CCR-10-0439
Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis
Abstract
Purpose: To date, genomewide association studies have identified 10 genetic loci associated with colorectal cancer (CRC) susceptibility. We hypothesized that these loci might also affect cancer survival.
Experimental design: To determine whether single-nucleotide polymorphisms tagging these 10 loci influenced all-cause and CRC-specific mortality, we prospectively followed survival outcomes for 2,838 Scottish patients recruited soon after a diagnosis of CRC. Survival analysis was conducted using Cox proportional hazard models adjusted for American Joint Committee on Cancer stage, age, and sex.
Results: None of the single-nucleotide polymorphisms were found to be statistically significantly associated with all-cause or CRC-specific mortality.
Conclusions: We conclude that none of the 10 common genetic variants thus far shown to be associated with CRC risk are associated with survival from CRC.
Copyright 2010 AACR.
References
-
- Koessler T, Azzato EM, Perkins B, et al. Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer. Int J Cancer. 2009;124:1887–91. - PubMed
-
- Galon J, Fridman WH, Pages F. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. Cancer Res. 2007;67:1883–6. - PubMed
-
- Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K. Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol. 2007;8:1001–6. - PubMed
-
- Kim JG, Chae YS, Sohn SK, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res. 2008;14:62–6. - PubMed
Publication types
MeSH terms
Grants and funding
- A3758/CRUK_/Cancer Research UK/United Kingdom
- C348/A3758/CRUK_/Cancer Research UK/United Kingdom
- MC_U127527198/MRC_/Medical Research Council/United Kingdom
- C26031/A11378/CRUK_/Cancer Research UK/United Kingdom
- 11378/CRUK_/Cancer Research UK/United Kingdom
- U.1275.03.004(61091)/MRC_/Medical Research Council/United Kingdom
- C31250/A10107/CRUK_/Cancer Research UK/United Kingdom
- A6361/CRUK_/Cancer Research UK/United Kingdom
- C348/A8896/CRUK_/Cancer Research UK/United Kingdom
- K/OPR/2/2/D333/CSO_/Chief Scientist Office/United Kingdom
- G0000657-53203/MRC_/Medical Research Council/United Kingdom
- CZB/4/449/CSO_/Chief Scientist Office/United Kingdom
- CZB/4/94/CSO_/Chief Scientist Office/United Kingdom
- A8896/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
